SlideShare une entreprise Scribd logo
1  sur  34
Congestive Heart Failure
Congestive Heart Failure
Definition
• Impaired cardiac pumping, heart is
unable to pump adequate amount of
blood to meet metabolic needs
• Associated with long-standing HTN and
CAD
Factors Affecting Cardiac Output
Cardiac Output
Preload
Afterload Contractility
Heart Rate Stroke Volume= X
Factors Affecting Cardiac Output
• Preload
– The volume of blood/amount of fiber stretch
in the ventricles at the end of diastole (i.e.,
before the next contraction)
Factors Affecting Cardiac Output
• Preload increases with:
• Fluid volume increases
• Vasoconstriction (“squeezes” blood from
vascular system into heart)
• Preload decreases with
• Fluid volume losses
• Vasodilation (able to “hold” more blood, therefore
less returning toheart)
End Diastolic Volume
(preload)
Cardiac
Output
Factors Affecting Cardiac Output
• Afterload
– The resistance against which the ventricle must
pump. Excessive afterload = difficult to pump
blood → reduced CO/SV
– Afterload increased with:
• Hypertension
• Vasoconstriction
– Afterload decreased with:
• Vasodilation
Factors Affecting Cardiac Output
• Contractility
– Ability of the heart muscle to contract; relates
to the strength of contraction.
Pathophysiology of CHF
• Vasoconstriction: ↑’s the resistance against
which heart has to pump (i.e., ↑’s afterload), and
may therefore ↓ CO
• Na and water retention: ↑’s fluid volume, which
↑’s preload. If too much “stretch” (d/t too much
fluid) → ↓ strength of contraction and ↓’s CO
• Excessive tachycardia → ↓’d diastolic filling
time → ↓’d ventricular filling → ↓’d CO
Congestive Heart Failure
Risk Factors
• CAD
• Age
• HTN
• Obesity
• Cigarette smoking
• Diabetes mellitus
• High cholesterol
Congestive Heart Failure
Etiology
• May be caused by any interference with
normal mechanisms regulating cardiac
output (CO)
• Common causes
– HTN
– Myocardial infarction
– Dysrhythmias
– Valvular disorders
2 Types of Heart Failure
Systolic Dysfunction
(Contraction) 2/3 of Patients
♥ The heart becomes weak
and enlarged
♥ The weakened heart
muscle can’t contract
♥ Not enough blood is
pumped from the
chambers
Diastolic Dysfunction
(Relaxation)
♥ Chambers don’t fill up so
less blood goes to the
lungs and body
♥ Stiff heart muscle can’t
relax
♥ Not enough blood fills the
chambers
What is an Ejection Fraction? (EF)
The amount of blood that pumps out of
the heart with each beat
♥ Normal EF = 50 – 65%
♥ Damaged Heart Muscle EF = 40%
♥ Potential Heart Transplant EF = 20%
When the EF is Abnormal
What Happens in the Body?
♥ Less blood goes to the brain that may make you
feel confused or dizzy
♥ Your lungs may fill up with fluid making you feel
short of breath
♥ Your kidneys may not be able to get rid of the
fluid
♥ Your belly, ankles and feet may swell up
Other Signs and Symptoms of CHF
♥ Extreme Fatigue
♥ Frequent Coughing
♥ Sudden Weight Gain
♥ Chest Pain or Pressure
♥ Nausea, Loss of Appetite or Bloating
♥ Decreased Urination
Acute Congestive Heart Failure
Clinical Manifestations
• Pulmonary edema
– Agitation
– Pale or cyanotic
– Cold
– Severe dyspnea
– Tachypnea
– Pink, frothy sputum
Chronic Congestive Heart Failure
Clinical Manifestations
• Fatigue
• Dyspnea
– Paroxysmal nocturnal dyspnea (PND)
• Tachycardia
• Edema – (lung, liver, abdomen, legs)
• Nocturia
Chronic Congestive Heart Failure
Clinical Manifestations
• Behavioral changes
– Restlessness, confusion, ↓ attention
• Chest pain (d/t ↓ CO and ↑ myocardial work)
• Weight changes (r/t fluid retention)
• Skin changes
– Dusky appearance
New York Heart Association
Functional Classification
Class I
No symptoms with
ordinary activity
Class II
Slight limitation of
physical activity
results in fatigue,
shortness of breath,
chest pain or
irregular heart beat
Class III
Marked limitation of
physical activity.
Comfortable at rest, but
less than ordinary
physical activity results
in fatigue, irregular
heart beat, pain or
shortness of breath
Class IV
Unable to carry out any
physical activity without
discomfort
All symptoms in class III
even at rest
Congestive Heart Failure
Diagnostic Studies
• Primary goal is to determine underlying
cause
– Physical exam
– Chest x-ray
– ECG
– ECHO
Pharmacotherapy
• Reduction of volume overload (reduce preload)
– Diuretics
• Ventricular unloading (reduce afterload)
– Acute: nitroglycerin, sodium nitroprusside
– Chronic: inhibit renin-angiotensin-aldosterone system,
diuretics, ACE inhibitors, angiotensin antagonists
– Beta-blockers (also reduce sympathetic activation)
• Inotropic interventions
– Acute: dobutamine
– Chronic: phosphodiesterase inhibitors, digitalis
1. ACE inhibitors
2. Diuretics
3. Inotropic drugs
• Cardiac glycosides - Digitalis
• β-agonist (Dobutamine) &
• PDE inhibitors (Amirinone, milrinone)
4. Vasodilators
• Arteriolar-Hydralzine, minoxidil
• Ca blockers- Nifedipine
• K openers- Nicorandil
• Venous-GTN
5. β-Adrenergic blockers – carveidilol,
metoprolol
Cardiac Disorders
Cardiac Glycosides
• Digitalis - One of the oldest drugs
- Effective in treating congestive heart
failure (CHF)
- peripheral & lung tissues become
congested = CHF
• CHF can be left sided or right sided
• Cardiac glycosides = digitalis glycosides
- inhibits the Na - K pump inc.
intracellular Ca
cardiac muscle fibers contract more
efficiently
- Digitalis = 3 effects on the heart 1) +
inotropic action (inc. myocard. contraction)
2) - chronotropic action (dec. HR) #) -
dromotropic action (dec. conduction of the
heart cells
SR
ATP
ADP
Ca2+
Ca2+
3Na
+
Contraction
NaCaX
ATPase
3Na+
ATPase
2K+
RyR
Digoxin
(-)
Ca2+
Ca2+
Net Effect
• Positive inotropic action (an
increase in the force and
velocity of myocardial systolic
contraction).
• A decrease in the degree of
activation of the sympathetic
nervous system and renin-
angiotensin system.
• Slowing of the heart rate and
decreased conduction velocity
through the AV node.
Pharmacokinetic Parameters• Absorption
– After oral dosing:
• Onset of action in 0.5 – 2 hours
• Peak effect reached in 2 – 6 hours
• Distribution
– Skeletal and heart muscle, but not into adipose tissue
– Up to 25-30% is bound to plasma proteins
• Metabolism
– Follows first-order kinetics
– Limited metabolism via sugar hydrolysis and lactone ring reduction
– Half-life = 1-2 days
• Excretion
– 60-80% excreted unchanged in urine
– Undergoes ACTIVE tubular secretion in the kidneys
• Action = inc. myocardial contraction (+
inotrophy),
and slows HR (- chronotropy), therefore regulating
the rate & rhythm of the heart
- Therapeutic serum levels = 0.5 - 2.0 ng/ml
• Use = moderate/severe systolic CHF, arrythmias
• SE = Dig. toxicity - bradycardia (pulse < 60),
anorexia, diarrhea, N&V, blurred vision, lethargy -
older adults more prone to toxicity
• DI - Other heart meds
Side Effects & Toxicities
• Yellow/green visual changes, halos around light
• N&V and diarrhea (50-75% of patients)
• Bradycardia (75-90% of patients)
• Fatigue, malaise, confusion, headache, etc.
• Anorexia
Clinical Considerations
• Doses must be individualized and depends on the type & severity of the
disease, age & weight of the patient, renal function, and concomitant
disease states
• Normal dosage range is 125 – 500 mcg (50 – 200 mcg capsules) a day in
a single dose
• Contraindications: Patients w/ ventricular fibrillation, renal impairment,
hypokalemia, hypomagnesemia, hypercalcemia, and pulmonary disease
• Patient must be advised not to take nonprescription cough or cold
medications, antacids, laxatives, or antidiarrheals without consulting the
pharmacist or physician
• Pregnancy category C
Congestive heartfailure
Congestive heartfailure

Contenu connexe

Tendances (20)

Centrally acting smr
Centrally acting smrCentrally acting smr
Centrally acting smr
 
Drugs for treating shock
Drugs for treating shockDrugs for treating shock
Drugs for treating shock
 
Anticonvulsant drugs
Anticonvulsant  drugsAnticonvulsant  drugs
Anticonvulsant drugs
 
Propranolol
PropranololPropranolol
Propranolol
 
Antianginal Drugs
Antianginal DrugsAntianginal Drugs
Antianginal Drugs
 
Antiplatelet Drugs
Antiplatelet DrugsAntiplatelet Drugs
Antiplatelet Drugs
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
 
Corticosteroids
CorticosteroidsCorticosteroids
Corticosteroids
 
Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology Adrenergic drugs - pharmacology
Adrenergic drugs - pharmacology
 
Skeletal muscle relaxants
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
 
Drugs for Congestive Heart Failure
Drugs for Congestive Heart FailureDrugs for Congestive Heart Failure
Drugs for Congestive Heart Failure
 
PARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGYPARACETAMOL PHARMACOLOGY
PARACETAMOL PHARMACOLOGY
 
Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.
 
Antianginal drug
Antianginal drugAntianginal drug
Antianginal drug
 
Beta blockers
Beta blockersBeta blockers
Beta blockers
 
Antihypertensive drugs
Antihypertensive drugsAntihypertensive drugs
Antihypertensive drugs
 
Loop diuretics
Loop diureticsLoop diuretics
Loop diuretics
 
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizersAntipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
Antipsychotics, antipsychotic drugs, major tranquilizers, tranquilizers
 
Drug therapy of shock
Drug therapy of shockDrug therapy of shock
Drug therapy of shock
 
Anticholinergic drugs
Anticholinergic drugsAnticholinergic drugs
Anticholinergic drugs
 

Similaire à Congestive heartfailure

Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure Ravi kumar
 
CONGESTIVE CARDIAC FAILURE.PPTX
CONGESTIVE CARDIAC FAILURE.PPTXCONGESTIVE CARDIAC FAILURE.PPTX
CONGESTIVE CARDIAC FAILURE.PPTXTHERock603333
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failureDr Htet
 
Nusing Management of CHF (English) Symposia
Nusing Management of CHF (English) SymposiaNusing Management of CHF (English) Symposia
Nusing Management of CHF (English) SymposiaThe CRUDEM Foundation
 
Congestive cardiac Failure
Congestive cardiac FailureCongestive cardiac Failure
Congestive cardiac Failureanishkumar123
 
Congestive Heart Failure.pptx
Congestive Heart Failure.pptxCongestive Heart Failure.pptx
Congestive Heart Failure.pptxMarjunJacosalem
 
Heart failure
Heart failure Heart failure
Heart failure AIIMS
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.pptOgunsina1
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failureDr. Waqas Nawaz
 
Pathophysiology of congestive heart failure
Pathophysiology of congestive heart failurePathophysiology of congestive heart failure
Pathophysiology of congestive heart failurethunderrajesh
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failureFuad Farooq
 

Similaire à Congestive heartfailure (20)

Congestive heart failure
Congestive heart failure Congestive heart failure
Congestive heart failure
 
CONGESTIVE CARDIAC FAILURE.PPTX
CONGESTIVE CARDIAC FAILURE.PPTXCONGESTIVE CARDIAC FAILURE.PPTX
CONGESTIVE CARDIAC FAILURE.PPTX
 
Drug therapy of congestive heart failure
Drug therapy of congestive heart failureDrug therapy of congestive heart failure
Drug therapy of congestive heart failure
 
Nusing Management of CHF (English) Symposia
Nusing Management of CHF (English) SymposiaNusing Management of CHF (English) Symposia
Nusing Management of CHF (English) Symposia
 
Heart System Disease
Heart System Disease  Heart System Disease
Heart System Disease
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
chf physiology (1).pptx
chf physiology (1).pptxchf physiology (1).pptx
chf physiology (1).pptx
 
Cvd khlid
Cvd khlidCvd khlid
Cvd khlid
 
CHF.pptx
CHF.pptxCHF.pptx
CHF.pptx
 
CHF.pptx
CHF.pptxCHF.pptx
CHF.pptx
 
Congestive cardiac Failure
Congestive cardiac FailureCongestive cardiac Failure
Congestive cardiac Failure
 
Congestive Heart Failure.pptx
Congestive Heart Failure.pptxCongestive Heart Failure.pptx
Congestive Heart Failure.pptx
 
Heart failure
Heart failure Heart failure
Heart failure
 
haemorrhagic shock
haemorrhagic shockhaemorrhagic shock
haemorrhagic shock
 
Cardiac Range.ppt
Cardiac Range.pptCardiac Range.ppt
Cardiac Range.ppt
 
Congestive heart failure
Congestive heart failureCongestive heart failure
Congestive heart failure
 
Ccf
CcfCcf
Ccf
 
Pathophysiology of congestive heart failure
Pathophysiology of congestive heart failurePathophysiology of congestive heart failure
Pathophysiology of congestive heart failure
 
Heart failure / cardiac failure
Heart failure / cardiac failureHeart failure / cardiac failure
Heart failure / cardiac failure
 
Heart failure...
Heart failure...Heart failure...
Heart failure...
 

Plus de pavithra vinayak

Mesurement of GFR and creatinine clearence
Mesurement of GFR and creatinine clearenceMesurement of GFR and creatinine clearence
Mesurement of GFR and creatinine clearencepavithra vinayak
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics pavithra vinayak
 
Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.pavithra vinayak
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationpavithra vinayak
 
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)pavithra vinayak
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens pavithra vinayak
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
protocol writing in clinical research
protocol writing in clinical research protocol writing in clinical research
protocol writing in clinical research pavithra vinayak
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacologypavithra vinayak
 
Anticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacologyAnticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacologypavithra vinayak
 
Antianginals - pharmacology
Antianginals - pharmacologyAntianginals - pharmacology
Antianginals - pharmacologypavithra vinayak
 
Vasomotor reversal of dale
Vasomotor reversal of daleVasomotor reversal of dale
Vasomotor reversal of dalepavithra vinayak
 
Paediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with linksPaediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with linkspavithra vinayak
 

Plus de pavithra vinayak (20)

Mesurement of GFR and creatinine clearence
Mesurement of GFR and creatinine clearenceMesurement of GFR and creatinine clearence
Mesurement of GFR and creatinine clearence
 
Effect of liver disease on pharmacokinetics
 Effect of liver disease on pharmacokinetics  Effect of liver disease on pharmacokinetics
Effect of liver disease on pharmacokinetics
 
Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.Genetic polymorphism in drug transport and drug targets.
Genetic polymorphism in drug transport and drug targets.
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
Therapeutic drug monitoring for immunosuppressive agents ( organ transplants)
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
protocol writing in clinical research
protocol writing in clinical research protocol writing in clinical research
protocol writing in clinical research
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Anticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacologyAnticholinergic drugs - pharmacology
Anticholinergic drugs - pharmacology
 
Antianginals - pharmacology
Antianginals - pharmacologyAntianginals - pharmacology
Antianginals - pharmacology
 
Alpha blockers class
Alpha blockers   classAlpha blockers   class
Alpha blockers class
 
03. adrenergic drugs
03. adrenergic drugs 03. adrenergic drugs
03. adrenergic drugs
 
Vasomotor reversal of dale
Vasomotor reversal of daleVasomotor reversal of dale
Vasomotor reversal of dale
 
Alcohol class
Alcohol classAlcohol class
Alcohol class
 
Gene expression
Gene expressionGene expression
Gene expression
 
Glaucoma
GlaucomaGlaucoma
Glaucoma
 
Paediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with linksPaediatric guidelines 2013 14 with links
Paediatric guidelines 2013 14 with links
 

Dernier

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...Poonam Aher Patil
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibitjbellavia9
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxnegromaestrong
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701bronxfugly43
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docxPoojaSen20
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfAyushMahapatra5
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfChris Hunter
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 

Dernier (20)

Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Seal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptxSeal of Good Local Governance (SGLG) 2024Final.pptx
Seal of Good Local Governance (SGLG) 2024Final.pptx
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 

Congestive heartfailure

  • 2. Congestive Heart Failure Definition • Impaired cardiac pumping, heart is unable to pump adequate amount of blood to meet metabolic needs • Associated with long-standing HTN and CAD
  • 3. Factors Affecting Cardiac Output Cardiac Output Preload Afterload Contractility Heart Rate Stroke Volume= X
  • 4. Factors Affecting Cardiac Output • Preload – The volume of blood/amount of fiber stretch in the ventricles at the end of diastole (i.e., before the next contraction)
  • 5. Factors Affecting Cardiac Output • Preload increases with: • Fluid volume increases • Vasoconstriction (“squeezes” blood from vascular system into heart) • Preload decreases with • Fluid volume losses • Vasodilation (able to “hold” more blood, therefore less returning toheart)
  • 7. Factors Affecting Cardiac Output • Afterload – The resistance against which the ventricle must pump. Excessive afterload = difficult to pump blood → reduced CO/SV – Afterload increased with: • Hypertension • Vasoconstriction – Afterload decreased with: • Vasodilation
  • 8. Factors Affecting Cardiac Output • Contractility – Ability of the heart muscle to contract; relates to the strength of contraction.
  • 9. Pathophysiology of CHF • Vasoconstriction: ↑’s the resistance against which heart has to pump (i.e., ↑’s afterload), and may therefore ↓ CO • Na and water retention: ↑’s fluid volume, which ↑’s preload. If too much “stretch” (d/t too much fluid) → ↓ strength of contraction and ↓’s CO • Excessive tachycardia → ↓’d diastolic filling time → ↓’d ventricular filling → ↓’d CO
  • 10. Congestive Heart Failure Risk Factors • CAD • Age • HTN • Obesity • Cigarette smoking • Diabetes mellitus • High cholesterol
  • 11. Congestive Heart Failure Etiology • May be caused by any interference with normal mechanisms regulating cardiac output (CO) • Common causes – HTN – Myocardial infarction – Dysrhythmias – Valvular disorders
  • 12. 2 Types of Heart Failure Systolic Dysfunction (Contraction) 2/3 of Patients ♥ The heart becomes weak and enlarged ♥ The weakened heart muscle can’t contract ♥ Not enough blood is pumped from the chambers Diastolic Dysfunction (Relaxation) ♥ Chambers don’t fill up so less blood goes to the lungs and body ♥ Stiff heart muscle can’t relax ♥ Not enough blood fills the chambers
  • 13. What is an Ejection Fraction? (EF) The amount of blood that pumps out of the heart with each beat ♥ Normal EF = 50 – 65% ♥ Damaged Heart Muscle EF = 40% ♥ Potential Heart Transplant EF = 20%
  • 14. When the EF is Abnormal What Happens in the Body? ♥ Less blood goes to the brain that may make you feel confused or dizzy ♥ Your lungs may fill up with fluid making you feel short of breath ♥ Your kidneys may not be able to get rid of the fluid ♥ Your belly, ankles and feet may swell up
  • 15. Other Signs and Symptoms of CHF ♥ Extreme Fatigue ♥ Frequent Coughing ♥ Sudden Weight Gain ♥ Chest Pain or Pressure ♥ Nausea, Loss of Appetite or Bloating ♥ Decreased Urination
  • 16. Acute Congestive Heart Failure Clinical Manifestations • Pulmonary edema – Agitation – Pale or cyanotic – Cold – Severe dyspnea – Tachypnea – Pink, frothy sputum
  • 17. Chronic Congestive Heart Failure Clinical Manifestations • Fatigue • Dyspnea – Paroxysmal nocturnal dyspnea (PND) • Tachycardia • Edema – (lung, liver, abdomen, legs) • Nocturia
  • 18. Chronic Congestive Heart Failure Clinical Manifestations • Behavioral changes – Restlessness, confusion, ↓ attention • Chest pain (d/t ↓ CO and ↑ myocardial work) • Weight changes (r/t fluid retention) • Skin changes – Dusky appearance
  • 19. New York Heart Association Functional Classification Class I No symptoms with ordinary activity Class II Slight limitation of physical activity results in fatigue, shortness of breath, chest pain or irregular heart beat
  • 20. Class III Marked limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in fatigue, irregular heart beat, pain or shortness of breath Class IV Unable to carry out any physical activity without discomfort All symptoms in class III even at rest
  • 21. Congestive Heart Failure Diagnostic Studies • Primary goal is to determine underlying cause – Physical exam – Chest x-ray – ECG – ECHO
  • 22. Pharmacotherapy • Reduction of volume overload (reduce preload) – Diuretics • Ventricular unloading (reduce afterload) – Acute: nitroglycerin, sodium nitroprusside – Chronic: inhibit renin-angiotensin-aldosterone system, diuretics, ACE inhibitors, angiotensin antagonists – Beta-blockers (also reduce sympathetic activation) • Inotropic interventions – Acute: dobutamine – Chronic: phosphodiesterase inhibitors, digitalis
  • 23. 1. ACE inhibitors 2. Diuretics 3. Inotropic drugs • Cardiac glycosides - Digitalis • β-agonist (Dobutamine) & • PDE inhibitors (Amirinone, milrinone)
  • 24. 4. Vasodilators • Arteriolar-Hydralzine, minoxidil • Ca blockers- Nifedipine • K openers- Nicorandil • Venous-GTN 5. β-Adrenergic blockers – carveidilol, metoprolol
  • 25. Cardiac Disorders Cardiac Glycosides • Digitalis - One of the oldest drugs - Effective in treating congestive heart failure (CHF) - peripheral & lung tissues become congested = CHF
  • 26. • CHF can be left sided or right sided • Cardiac glycosides = digitalis glycosides - inhibits the Na - K pump inc. intracellular Ca cardiac muscle fibers contract more efficiently - Digitalis = 3 effects on the heart 1) + inotropic action (inc. myocard. contraction) 2) - chronotropic action (dec. HR) #) - dromotropic action (dec. conduction of the heart cells
  • 28. Net Effect • Positive inotropic action (an increase in the force and velocity of myocardial systolic contraction). • A decrease in the degree of activation of the sympathetic nervous system and renin- angiotensin system. • Slowing of the heart rate and decreased conduction velocity through the AV node.
  • 29. Pharmacokinetic Parameters• Absorption – After oral dosing: • Onset of action in 0.5 – 2 hours • Peak effect reached in 2 – 6 hours • Distribution – Skeletal and heart muscle, but not into adipose tissue – Up to 25-30% is bound to plasma proteins • Metabolism – Follows first-order kinetics – Limited metabolism via sugar hydrolysis and lactone ring reduction – Half-life = 1-2 days • Excretion – 60-80% excreted unchanged in urine – Undergoes ACTIVE tubular secretion in the kidneys
  • 30. • Action = inc. myocardial contraction (+ inotrophy), and slows HR (- chronotropy), therefore regulating the rate & rhythm of the heart - Therapeutic serum levels = 0.5 - 2.0 ng/ml • Use = moderate/severe systolic CHF, arrythmias • SE = Dig. toxicity - bradycardia (pulse < 60), anorexia, diarrhea, N&V, blurred vision, lethargy - older adults more prone to toxicity • DI - Other heart meds
  • 31. Side Effects & Toxicities • Yellow/green visual changes, halos around light • N&V and diarrhea (50-75% of patients) • Bradycardia (75-90% of patients) • Fatigue, malaise, confusion, headache, etc. • Anorexia
  • 32. Clinical Considerations • Doses must be individualized and depends on the type & severity of the disease, age & weight of the patient, renal function, and concomitant disease states • Normal dosage range is 125 – 500 mcg (50 – 200 mcg capsules) a day in a single dose • Contraindications: Patients w/ ventricular fibrillation, renal impairment, hypokalemia, hypomagnesemia, hypercalcemia, and pulmonary disease • Patient must be advised not to take nonprescription cough or cold medications, antacids, laxatives, or antidiarrheals without consulting the pharmacist or physician • Pregnancy category C

Notes de l'éditeur

  1. 2 Types of Heart Failure Systolic Dysfunction (Contraction) 2/3 of Patients ♥ The heart becomes weak and enlarged ♥ The weakened heart muscle can’t contract ♥ Not enough blood is pumped from the chambers Diastolic Dysfunction (Relaxation) ♥ Chambers don’t fill up so less blood goes to the lungs and body ♥ Stiff heart muscle can’t relax ♥ Not enough blood fills the chambers
  2. What is an Ejection Fraction? (EF) The amount of blood that pumps out of the heart with each beat ♥ Normal EF = 50 – 65% ♥ Damaged Heart Muscle EF = 40% ♥ Potential Heart Transplant EF = 20%
  3. When the EF is Abnormal What Happens in the Body? ♥ Less blood goes to the brain that may make you feel confused or dizzy ♥ Your lungs may fill up with fluid making you feel short of breath ♥ Your kidneys may not be able to get rid of the fluid ♥ Your belly, ankles and feet may swell up
  4. Other Signs and Symptoms of CHF ♥ Extreme Fatigue ♥ Frequent Coughing ♥ Sudden Weight Gain ♥ Chest Pain or Pressure ♥ Nausea, Loss of Appetite or Bloating ♥ Decreased Urination
  5. New York Heart Association Functional Classification Class I No symptoms with ordinary activity Class II Slight limitation of physical activity results in fatigue, shortness of breath, chest pain or irregular heart beat
  6. New York Heart Association Functional Classification Class III Marked limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in fatigue, irregular heart beat, pain or shortness of breath Class IV Unable to carry out any physical activity without discomfort All symptoms in class III even at rest